genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
Rough Surf Ahead for California
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
Gene Therapy
Obsidian’s SWFT Response to COVID-19
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
News
Neuroscience
Proteins Required for Brain and Heart Function Activated by Pickled Capers
Drug Discovery
Red Blood Cells Harnessed as Nanoparticle Carriers for Vaccines
Autism
Autistic Traits in Mice Associated with Blood Vessel Defects
OMICs
Single-Cell Company Berkeley Lights Sets Terms for $153M IPO
Cancer
Tumor Microenvironment Analyzed by New Nano-Radiomics Approach
Insights
All
Trends for 2020
Coronavirus
Bacteriophages Could Be a Potential Game Changer in the Trajectory of…
Bioprocessing
Digital Biomanufacturing Needs a Digital Supply Chain
Bioprocessing
Continually Collecting Virions for Manufacturing Biotech Products
Bioprocessing
AI Promises to Accelerate Process Characterization
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Abbvie
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Drug Discovery
Red Blood Cells Harnessed as Nanoparticle Carriers for Vaccines
OMICs
Single-Cell Company Berkeley Lights Sets Terms for $153M IPO
Cancer
Tumor Microenvironment Analyzed by New Nano-Radiomics Approach
Coronavirus
Rough Surf Ahead for California
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Keynote Webinars
Life in the Time of Coronavirus
Upcoming Webinars
Uncover the True Identity of Your Particles with Comprehensive Particle Investigation
On Demand Webinars
GEN Live: COVID-19: Talking Next-Gen Diagnostics
Tutorial
Cultivation of Diverse and Rare Bacteria from Human Gut Microbiome
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Abbvie
Abbvie
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Abbvie
Catching Up to Coronavirus: Top 60 Treatments in Development
Abbvie
Assessing Coronavirus Impact on Wall Street
Abbvie
Allergan Sells Zenpep, Brazikumab as Regulators Review AbbVie $63B Deal
Abbvie
AbbVie Prepares for Life after Humira with Planned $63B Allergan Acquisition
Abbvie
AbbVie, Voyager Launch $1.5B+ Gene Therapy Collaboration Aimed at Parkinson’s, Other Synucleinopathies
Abbvie
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition...
Abbvie
FDA Approves First Non-Chemo Combination Therapy for a Form of Leukemia
Abbvie
AbbVie, Lupin to Develop MALT1 Inhibitors for Blood Cancers in $977M+...
Abbvie
AbbVie Takes Control of Cystic Fibrosis Collaboration with Galapagos
Abbvie
AbbVie, Alphabet-Backed Calico Extend Aging Collaboration by $1B, Three Years
Abbvie
Ablynx, Protagonist Report Phase II Failures
Abbvie
Biogen, AbbVie Withdraw MS Drug Zinbryta after Brain Disorders Spark EMA...
Abbvie
AbbVie, Voyager Launch Up-to-$1.1B+ Gene-Therapy Collaboration to Treat Alzheimer’s, Neurodegenerative Diseases
Abbvie
Regeneron to Lead $50M Exome Sequencing Consortium with UK Biobank
Abbvie
AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
